Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy

Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy

US Patent 9726669 · Granted Aug 8, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymeric dyes with linker groups comprising deoxyribose2025
Polymeric tandem dyes with linker groups2025
Polymeric tandem dyes with linker groups2025
Ultra bright dimeric or polymeric dyes with spacing linker groups2025
Method of formulating a pharmaceutical composition comprising administering an i2025
Treatment of a disease of the gastrointestinal tract with a JAK or other kinase 2024
Treatment of a disease of the gastrointestinal tract with an immunosuppressant2024
Programmable polymeric drugs2024
Programmable polymeric drugs2024
Gastrointestinal tract detection methods, devices and systems2024
Movable hybrid machining robot based on three-degree-of-freedom force-controlled2024
Polymeric dyes with linker groups comprising deoxyribose2024